Trial
NCT02968511
EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Milton S. Hershey Medical Center
Collaborators
OpenBiome
Condition
C.Difficile Colitis
Intervention
fecal microbiota transplant
Why stopped
Lack of eligible patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-27